Edgewell Personal Care (EPC) 10-Q 5 Aug 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jun. 30, 2021	Jul. 31, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2021
Document Transition Report	false
Entity File Number	001-15401
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Incorporation, State or Country Code	MO
Entity Tax Identification Number	43-1863181
Entity Address, Address Line One	6 Research Drive
Entity Address, City or Town	Shelton,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06484
City Area Code	(203)
Local Phone Number	944-5500
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	EPC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		54,363,273
Entity Central Index Key	0001096752
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Net sales	$ 573.7	$ 483.9	$ 1,544.1	$ 1,460.9
Cost of products sold	303.4	261.2	838.8	802.1
Gross profit	270.3	222.7	705.3	658.8
Selling, general and administrative expense	97.5	91.3	284	307.8
Advertising and sales promotion expense	81.9	67.5	191.5	155.6
Research and development expense	14.6	12.4	42.6	40.1
Restructuring charges	5.2	8	11.6	20.6
Operating income	71.1	43.5	175.6	134.7
Gain on sale of Infant and Pet Care business	0	0	0	(4.1)
Interest expense associated with debt	16.4	15.5	51.1	43.7
Cost of early retirement of long-term debt	0	26.2	26.1	26.2
Other expense (income), net	0.8	(3.5)	(0.2)	5.8
Earnings before income taxes	53.9	5.3	98.6	63.1
Income tax provision	13.1	0.6	25.7	16.5
Net earnings	$ 40.8	$ 4.7	$ 72.9	$ 46.6
Basic net earnings per share	$ 0.75	$ 0.09	$ 1.34	$ 0.86
Diluted net earnings per share	$ 0.74	$ 0.09	$ 1.32	$ 0.86
Condensed Consolidated Statements of Comprehensive Income
Net earnings	$ 40.8	$ 4.7	$ 72.9	$ 46.6
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	9.1	14.5	23	8.1
Pension and postretirement activity, net of tax	(0.7)	(1.1)	(1.3)	(1.8)
Deferred gain (loss) on hedging activity, net of tax	0.2	(1.8)	3.5	(1.5)
Total other comprehensive income, net of tax	8.6	11.6	25.2	4.8
Total comprehensive income	$ 49.4	$ 16.3	$ 98.1	$ 51.4

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Pension and postretirement activity, tax	$ (0.2)	$ (0.3)	$ (0.2)	$ (0.4)
Deferred gain (loss) on hedging activity, tax	$ 0.1	$ (0.8)	$ 1.7	$ (0.7)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Current assets
Cash and cash equivalents	$ 437.5	$ 364.7
Trade receivables, less allowance for doubtful accounts	149.6	158.8
Inventories	359.2	314.1
Other current assets	155.7	146
Total current assets	1,102	983.6
Property, plant and equipment, net	358.1	370.9
Goodwill	1,166.9	1,159.7
Other intangible assets, net	914.4	928.1
Other assets	105.8	98.6
Total assets	3,647.2	3,540.9
Current liabilities
Notes payable	24.8	21.1
Accounts payable	215.9	181.9
Other current liabilities	306.4	307.5
Total current liabilities	547.1	510.5
Long-term debt	1,233.6	1,237.9
Deferred income tax liabilities	103.4	102.5
Other liabilities	251.5	257.1
Liabilities, Total	2,135.6	2,108
Shareholders’ equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,624.7	1,631.8
Retained earnings	829.9	782.4
Common shares in treasury at cost	(777.3)	(790.4)
Accumulated other comprehensive loss	(166.4)	(191.6)
Total shareholders’ equity	1,511.6	1,432.9
Total liabilities and shareholders’ equity	$ 3,647.2	$ 3,540.9

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 7.4	$ 8.2
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	54,358,629	54,355,183
Treasury shares (in shares)	10,893,360	10,896,806

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash Flow from Operating Activities
Net earnings	$ 72.9	$ 46.6
Depreciation and amortization	65.9	65.5
Share-based compensation expense	19.6	15.1
Loss on sale of assets	0.6	1.2
Gain on sale of Infant and Pet Care business	0	(4.1)
Deferred compensation payments	(9.2)	(8.7)
Deferred income taxes	(1.3)	(16.1)
Cost of early retirement of long-term debt	26.1	26.2
Other, net	(0.8)	7.3
Change in operating assets and liabilities	(17.9)	(14.4)
Net cash from operating activities	155.9	118.6
Cash Flow from Investing Activities
Capital expenditures	(34.1)	(26.9)
Proceeds from sale of Infant and Pet Care business	7.5	95.8
Acquisitions, net of cash acquired	(0.3)	0
Collection of deferred purchase price on accounts receivable sold	2.6	3.9
Payments for other investing activities	(1.8)	(1.5)
Net Cash Provided by (Used in) Investing Activities, Total	(26.1)	71.3
Cash Flow from Financing Activities
Cash proceeds from the issuance of Senior Notes due 2029	500	0
Cash payments on Senior Notes due 2022	(500)	0
Cash proceeds from the issuance of Senior Notes due 2028	0	750
Cash proceeds from debt with original maturities greater than 90 days	0	50
Cash payments on debt with original maturities greater than 90 days	0	(167)
Net increase in debt with original maturities of 90 days or less	2.4	1.7
Debt issuance costs for Senior Notes due 2029	(6.5)	0
Repayments of Senior Debt due 2021	0	600
Payments of Debt Issuance Costs for Senior Notes due 2028	0	10.4
Payments Of Debt Issuance Costs For Revolving Credit Facility	0	(3.6)
Cost of early debt retirement	(26.1)	(26.2)
Dividends to common shareholders	(16.7)	0
Repurchase of shares	(9.2)	0
Net financing inflow (outflow) from the Accounts Receivable Facility	0.8	(14.4)
Employee shares withheld for taxes	(4)	(1.7)
Proceeds (payments) for other financing activities	(0.6)	0
Net cash used by financing activities	(59.9)	(21.6)
Effect of exchange rate changes on cash	2.9	2
Cash and cash equivalents, beginning of period	364.7	341.6
Cash and cash equivalents, end of period	$ 437.5	$ 511.9

Condensed Consolidated Statem_4

Condensed Consolidated Statement of Changes in Shareholders' Equity Statement - USD ($) $ in Millions	Total	Common shares	Treasury shares	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(11,000,000)
Common shares, issued (in shares)		65,200,000
Total shareholders' equity at Sep. 30, 2019	$ 1,303.5	$ 0.7	$ (803.8)	$ 1,627.7	$ 714.8	$ (235.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	46.6				46.6
Foreign currency translation adjustments	8.1					8.1
Pension and postretirement activity, net of tax	(1.8)					1.8
Deferred gain (loss) on hedging activity, net of tax	(1.5)					(1.5)
Activity under share plans (in shares)			100,000
Activity under share plans (in usd)	13.3		$ 11.7	1.6	0
Total shareholders' equity at Jun. 30, 2020	1,368.2	$ 0.7	$ (792.1)	1,629.3	761.4	(231.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(10,900,000)
Common shares, issued (in shares)		65,200,000
Total shareholders' equity at Mar. 31, 2020	1,347.3	$ 0.7	$ (793.5)	1,626.1	756.7	(242.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	4.7				4.7
Foreign currency translation adjustments	14.5					14.5
Pension and postretirement activity, net of tax	(1.1)					1.1
Deferred gain (loss) on hedging activity, net of tax	(1.8)					(1.8)
Activity under share plans (in shares)			0
Activity under share plans (in usd)	4.6		$ 1.4	3.2	0
Total shareholders' equity at Jun. 30, 2020	$ 1,368.2	$ 0.7	$ (792.1)	1,629.3	761.4	(231.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(10,900,000)
Common shares, issued (in shares)		65,200,000
Treasury shares (in shares)	10,896,806		(10,900,000)
Common shares, issued (in shares)	65,251,989	65,200,000
Total shareholders' equity at Sep. 30, 2020	$ 1,432.9	$ 0.7	$ (790.4)	1,631.8	782.4	(191.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	72.9				72.9
Foreign currency translation adjustments	23					23
Pension and postretirement activity, net of tax	(1.3)					(1.3)
Deferred gain (loss) on hedging activity, net of tax	3.5					3.5
Dividends declared to common shareholders	(25.4)				(25.4)
Treasury shares repurchased (in usd)	$ (9.2)		$ (9.2)
Treasury shares repurchased (in shares)	(300,000)		(300,000)
Activity under share plans (in shares)			300,000
Activity under share plans (in usd)	$ 15.2		$ 22.3	(7.1)	0
Total shareholders' equity at Jun. 30, 2021	1,511.6	$ 0.7	$ (777.3)	1,624.7	829.9	(166.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)			(10,900,000)
Common shares, issued (in shares)		65,200,000
Total shareholders' equity at Mar. 31, 2021	1,464.1	$ 0.7	$ (781.3)	1,622	797.7	(175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	40.8				40.8
Foreign currency translation adjustments	9.1					9.1
Pension and postretirement activity, net of tax	(0.7)					(0.7)
Deferred gain (loss) on hedging activity, net of tax	0.2					0.2
Dividends declared to common shareholders	(8.6)				(8.6)
Activity under share plans (in shares)			0
Activity under share plans (in usd)	6.7		$ 4	2.7	0
Total shareholders' equity at Jun. 30, 2021	$ 1,511.6	$ 0.7	$ (777.3)	$ 1,624.7	$ 829.9	$ (166.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares (in shares)	10,893,360		(10,900,000)
Common shares, issued (in shares)	65,251,989	65,200,000

Background and Basis of Present

Background and Basis of Presentation	9 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company and its subsidiaries (collectively, “Edgewell” or the “Company”) is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, and feminine care categories. Edgewell operates in more than 20 countries with extensive retail reach across 50 markets. The Company conducts its business in the following three segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black®, Bulldog® and Cremo® men’s grooming products, and Wet Ones® products. • Feminine Care includes tampons, pads, and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands. Through December 2019, the Company also conducted business in its All Other segment which included infant care products, such as bottles, cups, and pacifiers, sold under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems. The Company completed the sale of the Infant and Pet Care business in December 2019. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”), under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 20, 2020. Recently Adopted Accounting Pronouncements. In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13 intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The new guidance applies to all financial instruments, including trade receivables, and requires the measurement of all expected credit losses for financial assets held at a reporting date to be based on historical experience, current conditions and reasonable and supportable forecasts. Previous guidance did not include forward-looking information. The Company adopted the standard effective as of October 1, 2020. The adoption of the guidance did not have a material impact on the Company’s financial statements. The Company evaluates the creditworthiness of customers when negotiating contracts and, as trade receivables are short term in nature, the timing between recognition of a credit loss under existing guidance and the new guidance was not materially different for the Company.

Business Combinations and Dives

Business Combinations and Divestitures	9 Months Ended
	Jun. 30, 2021
Business Combinations [Abstract]
Business Combinations and Divestitures	Business Combinations and Divestitures Cremo Holding Company, LLC On September 2, 2020, the Company completed the acquisition (“Acquisition”) of Cremo Holding Company, LLC (“Cremo”). The Company accounted for the Acquisition utilizing the acquisition method of accounting, which requires assets and liabilities to be recognized based on estimates of their acquisition date fair values. The determination of the values of the acquired assets and assumed liabilities, including goodwill and other intangible assets, requires significant judgement. We have calculated fair values of the assets and liabilities acquired from Cremo including goodwill and intangible assets and working capital. The Company completed the final fair value determination of the Acquisition in the first quarter of fiscal year 2021. The Company used variations of the income approach in determining the fair value of intangible assets acquired in the Acquisition. Specifically, we utilized the multi-period excess earnings method to determine the fair value of the definite lived customer relationships acquired and the relief from royalty method to determine the fair value of the definite lived trade name and proprietary technology acquired. Our determination of the fair value of the intangible assets acquired involved the use of significant estimates and assumptions related to revenue growth rates, discount rates, customer attrition rates, and royalty rates. Edgewell believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that marketplace participants would use. The Company’s purchase price allocation included net assets of $234.6 and consisted of working capital and other net assets of $11.5 (including cash of $0.7), other intangible assets of $95.1 and goodwill of $128.0, representing the value of expansion into new markets and channels of trade. The acquired goodwill is deductible for tax purposes. The intangible assets acquired consisted primarily of the Cremo trade name, customer relationships and product formulations with a weighted average useful life of 17 years. All assets are included in the Company’s Sun and Skin Care segment. The Company noted that the net sales and net earnings of Cremo from the beginning of fiscal 2020 through the date of the closing of the Acquisition were not material relative to the total net sales and net earnings of the Company during fiscal 2020, and thus pro-forma results for Cremo were not disclosed in accordance with Accounting Standards Codification 805. Acquisition and integration costs related to Cremo totaling $1.3 and $3.3 for the three and nine months ended June 30, 2021, respectively, were included in Selling, general and administrative expense (“SG&A”) in the Condensed Consolidated Statements of Earnings and Comprehensive Income. Additionally, acquisition costs of $1.3 were included in Cost of products sold for the nine months ended June 30, 2021. Sale of Infant and Pet Care Business

Restructuring Charges

Restructuring Charges	9 Months Ended
	Jun. 30, 2021
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Project Fuel Project Fuel is an enterprise-wide transformational initiative launched in the second quarter of fiscal 2018 to address all aspects of our business and cost structure, simplifying and transforming our organization, structure and key processes. Project Fuel is facilitating further re-investment in our growth strategy while enabling us to achieve our desired future state operations. The Company does not include Project Fuel restructuring costs in the results of its reportable segments. However, the estimated impact of allocating such charges to segment results for the three and nine months ended June 30, 2021 and 2020, respectively, would have been as follows: Three Months Ended June 30, 2021 Wet Shave Sun and Skin Care Feminine Care Corporate Total Project Fuel Severance and related benefit costs $ 0.7 $ — $ — $ 0.6 1.3 Asset impairment and accelerated depreciation 0.2 — — — 0.2 Consulting, project implementation and management, and other exit costs 0.3 — 0.3 6.1 6.7 Total restructuring $ 1.2 $ — $ 0.3 $ 6.7 $ 8.2 Nine Months Ended June 30, 2021 Wet Shave Sun and Skin Care Feminine Care Corporate Total Project Fuel Severance and related benefit costs $ 1.6 $ 0.1 $ — $ 3.9 $ 5.6 Asset impairment and accelerated depreciation 0.4 — — — 0.4 Consulting, project implementation and management, and other exit costs 1.1 0.1 0.3 10.6 12.1 Total restructuring $ 3.1 $ 0.2 $ 0.3 $ 14.5 $ 18.1 Three Months Ended June 30, 2020 Wet Shave Sun and Skin Care Feminine Care Corporate Total Project Fuel Severance and related benefit costs $ — $ 0.2 $ — $ 5.0 5.2 Asset impairment and accelerated depreciation 0.6 — — — 0.6 Consulting, project implementation and management, and other exit costs 1.9 0.2 0.1 2.4 4.6 Total restructuring $ 2.5 $ 0.4 $ 0.1 $ 7.4 $ 10.4 Nine Months Ended June 30, 2020 Wet Shave Sun and Skin Care Feminine Care Corporate Total Project Fuel Severance and related benefit costs $ 0.2 $ 0.2 $ — $ 6.8 $ 7.2 Asset impairment and accelerated depreciation 1.6 — — — 1.6 Consulting, project implementation and management, and other exit costs 7.7 0.4 0.3 13.6 22.0 Total restructuring $ 9.5 $ 0.6 $ 0.3 $ 20.4 $ 30.8 Pre-tax SG&A of $2.8 and $6.2 for the three and nine months ended June 30, 2021, respectively, and $2.3 and $10.0 for the three and nine months ended June 30, 2020, respectively, associated with certain information technology enablement expenses and compensation expenses related to Project Fuel were included in Consulting, project implementation and management, and other exit costs. Pre-tax Cost of products sold of $0.2 and $0.3 for the three and nine months ended June 30, 2021, respectively, and $0.1 and $0.2 for the three and nine months ended June 30, 2020, respectively, related to inventory write-offs associated with Project Fuel, were included in Asset impairment and accelerated depreciation. The following table summarizes the restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2021: Utilized October 1, 2020 Charge to Other (1) Cash Non-Cash June 30, Restructuring Severance and related benefit costs $ 4.3 $ 5.6 $ 0.1 $ (9.6) $ — $ 0.4 Asset impairment and accelerated depreciation — 0.4 — — (0.4) — Consulting, project implementation and management, and other exit costs 1.1 12.1 — (9.4) — 3.8 Total restructuring $ 5.4 $ 18.1 $ 0.1 $ (19.0) $ (0.4) $ 4.2 (1) Includes the impact of currency translation.

Income Taxes

Income Taxes	9 Months Ended
	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three and nine months ended June 30, 2021, the Company had income tax expense of $13.1 and $25.7, respectively, on Earnings before income taxes of $53.9 and $98.6, respectively. The effective tax rate for the three and nine months ended June 30, 2021 was 24.2% and 26.1%, respectively. The difference between the federal statutory rate and the effective rate for the three and nine months ended June 30, 2021 is primarily due to the unfavorable mix of earnings in higher tax rate jurisdictions as well as unfavorable global intangible low-tax income and Internal Revenue Service Code Section 162(m) permanent adjustments. For the three and nine months ended June 30, 2020, the Company had income tax expense of $0.6 and $16.5, respectively, on Earnings before income taxes of $5.3 and $63.1, respectively. The effective tax rate for the three and nine months ended June 30, 2020 was 11.9% and 26.1%, respectively. The difference between the federal statutory rate and the effective rate for the three months ended June 30, 2020 was primarily due to the favorable mix of earnings in lower tax rate jurisdictions. The difference between the federal statutory rate and the effective rate for the nine months ended June 30, 2020 was primarily due to the unfavorable impact of the sale of the Infant and Pet Care business.

Earnings per Share

Earnings per Share	9 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent (“RSE”) awards. The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Basic weighted-average shares outstanding 54.4 54.3 54.4 54.3 Effect of dilutive securities: RSE awards 1.0 0.3 0.7 0.2 Total dilutive securities 1.0 0.3 0.7 0.2 Diluted weighted-average shares outstanding 55.4 54.6 55.1 54.5 For the three and nine months ended June 30, 2021, the calculation of diluted weighted-average shares outstanding excludes 0.9 of share options because the effect of including these awards was anti-dilutive. For the three and nine months ended June 30, 2020, the calculation of diluted weighted-average shares outstanding excludes 0.7 of share options and 0.1 of RSE awards because the effect of including these awards was anti-dilutive.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine Total Gross balance at October 1, 2020 $ 967.2 $ 356.8 $ 206.7 $ 1,530.7 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance at October 1, 2020 $ 598.2 $ 354.8 $ 206.7 $ 1,159.7 Changes in the nine-month period ended June 30, 2021 Cremo acquisition measurement period adjustment — 0.3 — 0.3 Cumulative translation adjustment 2.9 1.0 3.0 6.9 Gross balance at June 30, 2021 $ 970.1 $ 358.1 $ 209.7 $ 1,537.9 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance at June 30, 2021 $ 601.1 $ 356.1 $ 209.7 $ 1,166.9 The following table sets forth definite-lived intangible assets by class: June 30, 2021 September 30, 2020 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 256.3 $ 54.7 $ 201.6 $ 256.2 $ 45.4 $ 210.8 Technology and patents 79.3 75.9 3.4 79.1 75.3 3.8 Customer related and other 222.3 115.8 106.5 219.9 107.8 112.1 Total amortizable intangible assets $ 557.9 $ 246.4 $ 311.5 $ 555.2 $ 228.5 $ 326.7 Amortization expense was $5.5 and $16.6 for the three and nine months ended June 30, 2021, respectively, and $4.2 and $12.7 for the three and nine months ended June 30, 2020, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2021 and for fiscal 2022, 2023, 2024, 2025 and 2026 is $5.5, $22.1, $22.0, $21.9, $21.9 and $21.7, respectively, and $196.4 thereafter. The Company had indefinite-lived intangible assets of $602.9 ($183.9 in Wet Shave, $389.1 in Sun and Skin Care, and $29.9 in Feminine Care) at June 30, 2021, an increase of $1.5 from September 30, 2020, which was the result of foreign currency fluctuations. The Company had indefinite-lived trade names and brands of $601.4 ($183.1 in Wet Shave, $388.4 in Sun and Skin Care, and $29.9 in Feminine Care) at September 30, 2020.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	9 Months Ended
	Jun. 30, 2021
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information June 30, September 30, Inventories Raw materials and supplies $ 56.6 $ 58.5 Work in process 79.5 71.5 Finished products 223.1 184.1 Total inventories $ 359.2 $ 314.1 Other Current Assets Miscellaneous receivables $ 28.9 $ 23.3 Inventory returns receivable 1.0 1.0 Prepaid expenses 72.3 64.8 Value added tax collectible from customers 20.1 20.4 Income taxes receivable 22.0 26.3 Other 11.4 10.2 Total other current assets $ 155.7 $ 146.0 Property, Plant and Equipment Land $ 19.3 $ 19.3 Buildings 144.0 142.2 Machinery and equipment 1,042.4 1,014.2 Capitalized software costs 55.4 53.6 Construction in progress 38.4 32.7 Total gross property, plant and equipment 1,299.5 1,262.0 Accumulated depreciation and amortization (941.4) (891.1) Total property, plant and equipment, net $ 358.1 $ 370.9 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 63.0 $ 49.4 Accrued trade allowances 29.5 30.8 Accrued salaries, vacations and incentive compensation 50.7 62.6 Income taxes payable 12.5 13.4 Returns reserve 45.9 44.8 Restructuring reserve 4.2 5.4 Value added tax payable 9.3 6.8 Deferred compensation 5.9 5.9 Short term lease obligation 10.7 9.1 Customer advance payments 3.4 1.4 Dividends payable 8.2 — Other 63.1 77.9 Total other current liabilities $ 306.4 $ 307.5 Other Liabilities Pensions and other retirement benefits $ 119.0 $ 121.0 Deferred compensation 22.6 28.2 Long term lease obligation 42.4 34.6 Other non-current liabilities 67.5 73.3 Total other liabilities $ 251.5 $ 257.1

Leases

Leases	9 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Leases	Leases A lease is defined as a contract, or part of a contract, that conveys the right to control the use of identified property, plant or equipment over a contracted period in exchange for payment. The Company evaluates if an arrangement is a lease at the effective date of the agreement. For operating leases entered into prior to October 1, 2019, the right of use (“ROU”) assets and operating lease liabilities are recognized on the balance sheet based on the present value of the remaining future minimum payments over the lease term from the implementation date. Certain leases include an option to either renew or terminate the lease. For purposes of calculating lease liabilities, these options are included within the lease term when it has become reasonably certain that the Company will exercise such options. Leases entered into subsequent to October 1, 2019 calculate the operating lease ROU asset and operating lease liabilities based on the present value of minimum payments over the lease term at the effective date of the lease. The Company leases certain offices and manufacturing facilities, warehouses, employee vehicles and certain manufacturing related equipment. Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheet. All recorded leases are classified as operating leases, and lease expense is recognized on a straight-line basis over the lease term. The Company has elected to utilize the package of practical expedients which allows it to carryforward its historical lease classification, its assessment on whether a contract was or contains a lease, and its assessment of initial direct costs for any leases that existed prior to October 1, 2019. Additionally, the Company has elected as an accounting policy not to separate non-lease components from lease components and, instead, account for these components as a single lease component. The Company has made an accounting policy election not to recognize ROU assets and lease liabilities for leases that, as of October 1, 2019, are for 12 months or less. For leases that do not provide an implicit rate, the Company uses its secured incremental borrowing rate, based on the information available for leases, including the lease term and interest rate environment in the country in which the lease exists, to calculate the present value of the future lease payments. A summary of the Company's lease information is as follows: June 30, September 30, Assets Classification Right of use assets Other assets $ 52.9 $ 43.5 Liabilities Current lease liabilities Other current liabilities $ 10.7 $ 9.1 Long-term lease liabilities Other liabilities 42.4 34.6 Total lease liabilities $ 53.1 $ 43.7 Other information Weighted-average remaining lease term (years) 10 12 Weighted-average incremental borrowing rate 6.6 % 7.2 % Three Months Ended June 30, 2021 Three Months Ended June 30, 2020 Nine Months Ended June 30, 2021 Nine Months Ended June 30, 2020 Statement of Earnings Lease cost (1) $ 3.6 $ 3.3 $ 11.0 $ 10.4 Other information Leased assets obtained in exchange for new lease liabilities $ 1.1 $ 0.5 $ 18.8 $ 1.1 Cash paid for amounts included in the measurement of lease liabilities $ 3.6 $ 3.4 $ 11.0 $ 10.4 (1) Lease expense is included in Cost of products sold or SG&A expense based on the nature of the lease. Short-term lease expense is excluded from this amount and is not material. The Company's future lease payments including reasonably assured renewal options under lease agreements are as follows: Lease liability repayments June 30, 2021 Remainder of fiscal 2021 $ 3.3 2022 12.0 2023 10.1 2024 8.0 2025 7.1 2026 and thereafter 39.2 Total future minimum lease commitments 79.7 Less: Imputed interest (26.6) Present value of lease liabilities $ 53.1

Accounts Receivable Facility

Accounts Receivable Facility	9 Months Ended
	Jun. 30, 2021
Transfers and Servicing [Abstract]
Accounts receivable facility	Accounts Receivable Facility The Company participates in a $150 uncommitted master accounts receivable purchase agreement with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (the “Accounts Receivable Facility”). Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being de-recognized from the Consolidated Balance Sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase and sale of receivables under the Accounts Receivable Facility is intended to be an absolute and irrevocable transfer without recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company continues to have collection and servicing responsibilities for the receivables sold and receives separate compensation for their servicing. The compensation received is considered acceptable servicing compensation and, as such, the Company does not recognize a servicing asset or liability. As of June 30, 2021, the discount rate used to determine the purchase price for the subject receivables is based upon LIBOR plus a margin applicable to the specified obligor.

Debt

Debt	9 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: June 30, September 30, Senior notes, fixed interest rate of 4.7%, due 2022 $ — $ 500.0 Senior notes, fixed interest rate of 5.5%, due 2028 750.0 750.0 Senior notes, fixed interest rate of 4.1%, due 2029 500.0 — U.S. revolving credit facility due 2025 — — Total long-term debt, including current maturities 1,250.0 1,250.0 Less unamortized debt issuance costs and discount (1) (2) 16.4 12.1 Total long-term debt $ 1,233.6 $ 1,237.9 (1) At June 30, 2021, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $10.2 and $6.2, respectively. At September 30, 2020, the balance for the Senior Notes due 2022 and the Senior Notes due 2028 are reflected net of debt issuance costs of $0.6 and $11.3, respectively. (2) At September 30, 2020, the balance for the Senior Notes due 2022 was reflected net of discount of $0.2. The Company had outstanding variable-rate international borrowings, recorded in Notes payable, of $24.8 and $21.1 as of June 30, 2021 and September 30, 2020, respectively. Issuance of Senior Notes due 2029 and Redemption of Senior Notes due 2022 On March 8, 2021, the Company entered into a new unsecured indenture agreement for 4.125% Senior Notes in the amount of $500 due April 1, 2029 (“2029 Notes”). The Company used the net proceeds from the issuance of the 2029 Notes, together with cash on hand, to satisfy and discharge the obligations outstanding for its 4.70% Senior Notes in the amount of $500 due 2022 (“2022 Notes”) and to pay fees associated therewith. The Company incurred $6.5 in bank, legal and other fees in connection with the issuance of the 2029 Notes, which will be deferred and amortized to interest expense over the term of these notes. Interest expense on the 2029 Notes is due semiannually on April 1 and October 1 with the first interest payment scheduled for October 1, 2021. In connection with the early repayment of the 2022 Notes, the Company recorded expense of $26.1 for the nine months ended June 30, 2021, which is included in “Cost of early debt retirements” in the Condensed Consolidated Statements of Earnings and Comprehensive Income. This expense included a premium of $25.5 and debt issuance cost write-offs of $0.6. The 2029 Notes are guaranteed, jointly and severally, by each of the Company’s direct and indirect wholly-owned domestic subsidiaries that guarantee the Company’s existing secured revolving credit facility (or certain replacements thereof) or that guarantee certain capital markets indebtedness of the Company, in each case provided that the amount of such credit facility or indebtedness exceeds a specified amount, for so long as they remain guarantors under such indebtedness and subject to release in certain other circumstances. The 2029 Notes and guarantees thereof are unsecured, unsubordinated indebtedness of the Company and the guarantors.

Retirement Plans

Retirement Plans	9 Months Ended
	Jun. 30, 2021
Retirement Benefits [Abstract]
Retirement Plans	Retirement PlansThe Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries, which are included in the information presented below. The plans provide retirement benefits based on years of service and compensation. The Company also sponsors or participates in several other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company’s net periodic pension and postretirement costs for these plans for the third quarter and nine months ended June 30 were as follows: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Service cost $ 1.1 $ 1.1 $ 3.3 $ 3.2 Interest cost 2.5 3.4 7.4 10.3 Expected return on plan assets (5.6) (5.8) (16.8) (17.3) Recognized net actuarial loss 2.3 2.2 6.9 6.8 Settlement loss recognized — 0.3 — 0.7 Net periodic cost $ 0.3 $ 1.2 $ 0.8 $ 3.7 The service cost component of the net periodic cost associated with the Company’s retirement plans is recorded to Cost of products sold and SG&A on the Condensed Consolidated Statement of Earnings and Comprehensive Income. The remaining net periodic cost is recorded to Other expense (income), net on the Condensed Consolidated Statement of Earnings and Comprehensive Income.

Equity

Equity	9 Months Ended
	Jun. 30, 2021
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity In January 2018, the Company’s Board of Directors (the “Board”) approved an authorization to repurchase up to 10.0 shares of the Company’s common stock, replacing the previous share repurchase authorization from May 2015. The Company repurchased 0.3 shares of its common stock for $9.2 during the nine months ended June 30, 2021. The Company has 9.7 shares of its common stock available for repurchase in the future under the Board’s authorization. Any future share repurchases may be made in the open market, privately negotiated transactions, or otherwise, and in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs, and other factors. On May 6, 2021, the Board declared a cash dividend of $0.15 per share of common stock outstanding. The dividend was paid on July 7, 2021 to holders of record as of the close of business on June 4, 2021. Dividends declared during the nine months ended June 30, 2021 totaled $25.4. Payments made for dividends during the nine months ended June 30, 2021 totaled $16.7.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
	Jun. 30, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The following table presents the changes in accumulated other comprehensive loss (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2020 $ (47.4) $ (142.1) $ (2.1) $ (191.6) OCI before reclassifications (1) 23.0 (6.3) 0.9 17.6 Reclassifications to earnings — 5.0 2.6 7.6 Balance at June 30, 2021 $ (24.4) $ (143.4) $ 1.4 $ (166.4) Foreign Pension and Hedging Total Balance at October 1, 2019 $ (77.3) $ (159.8) $ 1.2 $ (235.9) OCI before reclassifications (1) 8.1 (7.2) 0.3 1.2 Reclassifications to earnings — 5.4 (1.8) 3.6 Balance at June 30, 2020 $ (69.2) $ (161.6) $ (0.3) $ (231.1) (1) OCI is defined as other comprehensive income (loss). The following table presents the reclassifications out of AOCI: Three Months Ended Nine Months Ended Affected Line Item in the Details of AOCI Components 2021 2020 2021 2020 Gain / (Loss) on cash flow hedges Foreign exchange contracts $ (0.5) $ 1.0 $ (3.7) $ 2.6 Other income, net (0.5) 1.0 (3.7) 2.6 (0.1) 0.3 (1.1) 0.8 Income tax provision (0.4) 0.7 (2.6) 1.8 Amortization of defined benefit pension and postretirement items Actuarial losses $ (2.4) $ (2.2) $ (7.0) $ (6.8) (1) Settlements — (0.3) — (0.7) (1) (2.4) (2.5) (7.0) (7.5) (0.7) (0.7) (2.0) (2.1) Income tax provision (1.7) (1.8) (5.0) (5.4) Total reclassifications for the period $ (2.1) $ (1.1) $ (7.6) $ (3.6) (1) These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	9 Months Ended
	Jun. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management In the course of ordinary business, the Company enters into contractual arrangements (also referred to as derivatives) to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its counterparty netting arrangements. The section below outlines the types of derivatives that existed at June 30, 2021 and September 30, 2020, as well as the Company’s objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company’s sales is tied to currencies other than the U.S. dollar, the Company’s reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar, and the Australian dollar. Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local currency at the end of each month. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other income, net. The primary currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar. Cash Flow Hedges At June 30, 2021, the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective by the Company for accounting purposes in offsetting the associated risk. The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax gain of $2.2 and an unrealized pre-tax loss of $3.0 at June 30, 2021 and September 30, 2020, respectively, on these forward currency contracts, which are accounted for as cash flow hedges and included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at June 30, 2021 levels over the next 12 months, the majority of the pre-tax gain included in AOCI at June 30, 2021 is expected to be included in Other income, net. Contract maturities for these hedges extend into fiscal 2022. At June 30, 2021, there were 64 open foreign currency contracts with a total notional value of $133.1. Derivatives not Designated as Hedges The Company has entered into foreign currency derivative contracts, which are not designated as cash flow hedges for accounting purposes, to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures and, thus, are not subject to significant market risk. The change in the estimated fair value of the foreign currency contracts for the three and nine months ended June 30, 2021 resulted in a loss of $1.2 and gain of $0.7, respectively, compared to a gain of $0.3 and a loss of $0.2, respectively, for the three and nine months ended June 30, 2020, and was recorded in Other income, net in the Condensed Consolidated Statements of Earnings and Comprehensive Income. At June 30, 2021, there were five open foreign currency derivative contracts not designated as cash flow hedges with a total notional value of $42.0. The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) June 30, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 2.2 $ (3.0) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 0.7 $ (0.6) (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities. The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ (0.2) $ (1.6) $ 1.5 $ 0.4 Gain (loss) reclassified from AOCI into income (1) (2) (0.5) 1.0 (3.7) 2.6 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ (1.2) $ 0.3 $ 0.7 $ (0.2) (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk. (2) Gain (loss) was recorded in Other income, net. The following table provides financial assets and liabilities for balance sheet offsetting: At June 30, 2021 At September 30, 2020 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 3.6 $ (0.9) $ — $ (3.7) Gross amounts offset in the balance sheet (0.1) 0.3 — 0.1 Net amounts of assets (liabilities) presented in the balance sheet $ 3.5 $ (0.6) $ — $ (3.6) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets. The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: June 30, September 30, Liabilities at estimated fair value: Deferred compensation $ (28.4) $ (33.9) Derivatives - foreign currency contracts 2.9 (3.6) Net liabilities at estimated fair value $ (25.5) $ (37.5) The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. At June 30, 2021, the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates, and remaining maturities. At June 30, 2021 and September 30, 2020 the Company had no Level 1 financial assets or liabilities, other than pension plan assets, and no Level 3 financial assets or liabilities at June 30, 2021 and at September 30, 2020. At June 30, 2021 and September 30, 2020 the fair market value of fixed rate long-term debt was $1,314.6 and $1,323.1, respectively, compared to its carrying value of $1,250.0. The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of long-term debt, excluding the revolving credit facility, have been determined based on Level 2 inputs. Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company’s revolving credit facility, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings, and the revolving credit agreement have been determined based on Level 2 inputs.

Segment Data

Segment Data	9 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Segment Data	Segment Data For an overview of the Company’s segments, refer to Note 1 to Notes to Condensed Consolidated Financial Statements. Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, restructuring charges, and certain costs deemed non-recurring in nature, including evaluation, acquisition and integration costs, cost of early retirement of long-term debt, incremental pandemic expenses, gains or losses on the sale of businesses, and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management’s view on how it evaluates segment performance. The Company completed the sale of its Infant and Pet Care business in December 2019. As a result, no additional Net Sales or Segment Profit will be reported for the All Other segment in subsequent periods. The Company’s operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and, in most cases, combined sales force and management teams. The Company applies a fully allocated cost basis in which shared business functions are allocated between the segments. Segment net sales and profitability are presented below: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net Sales Wet Shave $ 304.9 $ 278.0 $ 876.7 $ 835.5 Sun and Skin Care 195.2 136.9 457.7 369.5 Feminine Care 73.6 69.0 209.7 229.1 All Other — — — 26.8 Total net sales $ 573.7 $ 483.9 $ 1,544.1 $ 1,460.9 Segment Profit Wet Shave $ 43.1 $ 44.6 $ 141.6 $ 142.0 Sun and Skin Care 45.0 23.5 86.4 67.9 Feminine Care 13.7 12.0 28.1 43.4 All Other — — — 3.1 Total segment profit 101.8 80.1 256.1 256.4 General corporate and other expenses (15.7) (17.7) (41.2) (41.9) Restructuring and related costs (1) (8.2) (10.4) (18.1) (30.8) Cost of early retirement of long-term debt — (26.2) (26.1) (26.2) Acquisition and integration costs (2) (1.3) (0.3) (4.6) (32.0) Gain on sale of Infant and Pet Care business — — — 4.1 COVID-19 expense (3) — (3.9) — (3.9) Feminine and Infant Care evaluation costs (4) — — — (0.3) Amortization of intangibles (5.5) (4.2) (16.6) (12.7) Interest and other expense, net (17.2) (12.1) (50.9) (49.6) Total earnings before income taxes $ 53.9 $ 5.3 $ 98.6 $ 63.1 (1) Includes pre-tax SG&A of $2.8 and $6.2 for the three and nine months ended June 30, 2021, respectively, and $2.3 and $10.0 for the three and nine months ended June 30, 2020, respectively, associated with certain information technology enablement expenses and incentive and retention compensation expenses for Project Fuel. Additionally, pre-tax Cost of products sold of $0.2 and $0.3 for the three and nine months ended June 30, 2021, respectively, and $0.1 and $0.2 for the three and nine months ended June 30, 2020, respectively, related to inventory write-offs associated with Project Fuel is included. (2) Includes pre-tax SG&A of $1.3 and $3.3 for the three and nine months ended June 30, 2021, respectively, and $0.3 and $32.0 for the three and nine months ended June 30, 2020, respectively, related to acquisition and integration costs. Additionally, Cost of products sold of $1.3 related to the valuation of acquired inventory for the nine months ended June 30, 2021 is included. (3) Includes pre-tax Cost of products sold of $3.9 for the three and nine months ended June 30, 2020 which included incremental costs as a result of the COVID-19 pandemic incurred by the Company related to higher benefit and emergency payments, supplies and freight. (4) Includes pre-tax SG&A of $0.3 for the nine months ended June 30, 2020. The following table presents the Company’s net sales by geographic area: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net Sales to Customers United States $ 336.4 $ 277.4 $ 889.0 $ 830.8 International 237.3 206.5 655.1 630.1 Total net sales $ 573.7 $ 483.9 $ 1,544.1 $ 1,460.9 Supplemental product information is presented below for net sales: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Razors and blades $ 271.9 $ 244.9 $ 780.6 $ 735.3 Tampons, pads, and liners 73.6 69.0 209.7 229.1 Sun care products 143.9 94.0 275.7 246.3 Grooming products 32.4 15.6 108.6 55.3 Wipes and other skin care 18.9 27.3 73.4 67.9 Shaving gels and creams 33.0 33.1 96.1 100.2 Infant care and other — — — 26.8 Total net sales $ 573.7 $ 483.9 $ 1,544.1 $ 1,460.9

Restructuring Charges (Tables)

Restructuring Charges (Tables)	9 Months Ended
	Jun. 30, 2021
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	The Company does not include Project Fuel restructuring costs in the results of its reportable segments. However, the estimated impact of allocating such charges to segment results for the three and nine months ended June 30, 2021 and 2020, respectively, would have been as follows: Three Months Ended June 30, 2021 Wet Shave Sun and Skin Care Feminine Care Corporate Total Project Fuel Severance and related benefit costs $ 0.7 $ — $ — $ 0.6 1.3 Asset impairment and accelerated depreciation 0.2 — — — 0.2 Consulting, project implementation and management, and other exit costs 0.3 — 0.3 6.1 6.7 Total restructuring $ 1.2 $ — $ 0.3 $ 6.7 $ 8.2 Nine Months Ended June 30, 2021 Wet Shave Sun and Skin Care Feminine Care Corporate Total Project Fuel Severance and related benefit costs $ 1.6 $ 0.1 $ — $ 3.9 $ 5.6 Asset impairment and accelerated depreciation 0.4 — — — 0.4 Consulting, project implementation and management, and other exit costs 1.1 0.1 0.3 10.6 12.1 Total restructuring $ 3.1 $ 0.2 $ 0.3 $ 14.5 $ 18.1 Three Months Ended June 30, 2020 Wet Shave Sun and Skin Care Feminine Care Corporate Total Project Fuel Severance and related benefit costs $ — $ 0.2 $ — $ 5.0 5.2 Asset impairment and accelerated depreciation 0.6 — — — 0.6 Consulting, project implementation and management, and other exit costs 1.9 0.2 0.1 2.4 4.6 Total restructuring $ 2.5 $ 0.4 $ 0.1 $ 7.4 $ 10.4 Nine Months Ended June 30, 2020 Wet Shave Sun and Skin Care Feminine Care Corporate Total Project Fuel Severance and related benefit costs $ 0.2 $ 0.2 $ — $ 6.8 $ 7.2 Asset impairment and accelerated depreciation 1.6 — — — 1.6 Consulting, project implementation and management, and other exit costs 7.7 0.4 0.3 13.6 22.0 Total restructuring $ 9.5 $ 0.6 $ 0.3 $ 20.4 $ 30.8 Pre-tax SG&A of $2.8 and $6.2 for the three and nine months ended June 30, 2021, respectively, and $2.3 and $10.0 for the three and nine months ended June 30, 2020, respectively, associated with certain information technology enablement expenses and compensation expenses related to Project Fuel were included in Consulting, project implementation and management, and other exit costs. Pre-tax Cost of products sold of $0.2 and $0.3 for the three and nine months ended June 30, 2021, respectively,
Schedule of Restructuring Activities and Related Accruals	The following table summarizes the restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2021: Utilized October 1, 2020 Charge to Other (1) Cash Non-Cash June 30, Restructuring Severance and related benefit costs $ 4.3 $ 5.6 $ 0.1 $ (9.6) $ — $ 0.4 Asset impairment and accelerated depreciation — 0.4 — — (0.4) — Consulting, project implementation and management, and other exit costs 1.1 12.1 — (9.4) — 3.8 Total restructuring $ 5.4 $ 18.1 $ 0.1 $ (19.0) $ (0.4) $ 4.2 (1) Includes the impact of currency translation.

Earnings per Share (Tables)

Earnings per Share (Tables)	9 Months Ended
	Jun. 30, 2021
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Basic weighted-average shares outstanding 54.4 54.3 54.4 54.3 Effect of dilutive securities: RSE awards 1.0 0.3 0.7 0.2 Total dilutive securities 1.0 0.3 0.7 0.2 Diluted weighted-average shares outstanding 55.4 54.6 55.1 54.5

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth goodwill by segment: Wet Sun and Skin Feminine Total Gross balance at October 1, 2020 $ 967.2 $ 356.8 $ 206.7 $ 1,530.7 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance at October 1, 2020 $ 598.2 $ 354.8 $ 206.7 $ 1,159.7 Changes in the nine-month period ended June 30, 2021 Cremo acquisition measurement period adjustment — 0.3 — 0.3 Cumulative translation adjustment 2.9 1.0 3.0 6.9 Gross balance at June 30, 2021 $ 970.1 $ 358.1 $ 209.7 $ 1,537.9 Accumulated goodwill impairment (369.0) (2.0) — (371.0) Net balance at June 30, 2021 $ 601.1 $ 356.1 $ 209.7 $ 1,166.9
Schedule of Amortizable Intangible Assets	The following table sets forth definite-lived intangible assets by class: June 30, 2021 September 30, 2020 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 256.3 $ 54.7 $ 201.6 $ 256.2 $ 45.4 $ 210.8 Technology and patents 79.3 75.9 3.4 79.1 75.3 3.8 Customer related and other 222.3 115.8 106.5 219.9 107.8 112.1 Total amortizable intangible assets $ 557.9 $ 246.4 $ 311.5 $ 555.2 $ 228.5 $ 326.7

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	9 Months Ended
	Jun. 30, 2021
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	June 30, September 30, Inventories Raw materials and supplies $ 56.6 $ 58.5 Work in process 79.5 71.5 Finished products 223.1 184.1 Total inventories $ 359.2 $ 314.1 Other Current Assets Miscellaneous receivables $ 28.9 $ 23.3 Inventory returns receivable 1.0 1.0 Prepaid expenses 72.3 64.8 Value added tax collectible from customers 20.1 20.4 Income taxes receivable 22.0 26.3 Other 11.4 10.2 Total other current assets $ 155.7 $ 146.0 Property, Plant and Equipment Land $ 19.3 $ 19.3 Buildings 144.0 142.2 Machinery and equipment 1,042.4 1,014.2 Capitalized software costs 55.4 53.6 Construction in progress 38.4 32.7 Total gross property, plant and equipment 1,299.5 1,262.0 Accumulated depreciation and amortization (941.4) (891.1) Total property, plant and equipment, net $ 358.1 $ 370.9 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 63.0 $ 49.4 Accrued trade allowances 29.5 30.8 Accrued salaries, vacations and incentive compensation 50.7 62.6 Income taxes payable 12.5 13.4 Returns reserve 45.9 44.8 Restructuring reserve 4.2 5.4 Value added tax payable 9.3 6.8 Deferred compensation 5.9 5.9 Short term lease obligation 10.7 9.1 Customer advance payments 3.4 1.4 Dividends payable 8.2 — Other 63.1 77.9 Total other current liabilities $ 306.4 $ 307.5 Other Liabilities Pensions and other retirement benefits $ 119.0 $ 121.0 Deferred compensation 22.6 28.2 Long term lease obligation 42.4 34.6 Other non-current liabilities 67.5 73.3 Total other liabilities $ 251.5 $ 257.1

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jun. 30, 2021
Leases [Abstract]
Summary of Lease Information	A summary of the Company's lease information is as follows: June 30, September 30, Assets Classification Right of use assets Other assets $ 52.9 $ 43.5 Liabilities Current lease liabilities Other current liabilities $ 10.7 $ 9.1 Long-term lease liabilities Other liabilities 42.4 34.6 Total lease liabilities $ 53.1 $ 43.7 Other information Weighted-average remaining lease term (years) 10 12 Weighted-average incremental borrowing rate 6.6 % 7.2 % Three Months Ended June 30, 2021 Three Months Ended June 30, 2020 Nine Months Ended June 30, 2021 Nine Months Ended June 30, 2020 Statement of Earnings Lease cost (1) $ 3.6 $ 3.3 $ 11.0 $ 10.4 Other information Leased assets obtained in exchange for new lease liabilities $ 1.1 $ 0.5 $ 18.8 $ 1.1 Cash paid for amounts included in the measurement of lease liabilities $ 3.6 $ 3.4 $ 11.0 $ 10.4
Lessee, Operating Lease, Liability, Maturity	The Company's future lease payments including reasonably assured renewal options under lease agreements are as follows: Lease liability repayments June 30, 2021 Remainder of fiscal 2021 $ 3.3 2022 12.0 2023 10.1 2024 8.0 2025 7.1 2026 and thereafter 39.2 Total future minimum lease commitments 79.7 Less: Imputed interest (26.6) Present value of lease liabilities $ 53.1

Debt (Tables)

Debt (Tables)	9 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: June 30, September 30, Senior notes, fixed interest rate of 4.7%, due 2022 $ — $ 500.0 Senior notes, fixed interest rate of 5.5%, due 2028 750.0 750.0 Senior notes, fixed interest rate of 4.1%, due 2029 500.0 — U.S. revolving credit facility due 2025 — — Total long-term debt, including current maturities 1,250.0 1,250.0 Less unamortized debt issuance costs and discount (1) (2) 16.4 12.1 Total long-term debt $ 1,233.6 $ 1,237.9 (1) At June 30, 2021, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $10.2 and $6.2, respectively. At September 30, 2020, the balance for the Senior Notes due 2022 and the Senior Notes due 2028 are reflected net of debt issuance costs of $0.6 and $11.3, respectively. (2) At September 30, 2020, the balance for the Senior Notes due 2022 was reflected net of discount of $0.2.

Retirement Plans (Tables)

Retirement Plans (Tables)	9 Months Ended
	Jun. 30, 2021
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Cost (Benefit)	The Company’s net periodic pension and postretirement costs for these plans for the third quarter and nine months ended June 30 were as follows: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Service cost $ 1.1 $ 1.1 $ 3.3 $ 3.2 Interest cost 2.5 3.4 7.4 10.3 Expected return on plan assets (5.6) (5.8) (16.8) (17.3) Recognized net actuarial loss 2.3 2.2 6.9 6.8 Settlement loss recognized — 0.3 — 0.7 Net periodic cost $ 0.3 $ 1.2 $ 0.8 $ 3.7

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Jun. 30, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in accumulated other comprehensive loss (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2020 $ (47.4) $ (142.1) $ (2.1) $ (191.6) OCI before reclassifications (1) 23.0 (6.3) 0.9 17.6 Reclassifications to earnings — 5.0 2.6 7.6 Balance at June 30, 2021 $ (24.4) $ (143.4) $ 1.4 $ (166.4) Foreign Pension and Hedging Total Balance at October 1, 2019 $ (77.3) $ (159.8) $ 1.2 $ (235.9) OCI before reclassifications (1) 8.1 (7.2) 0.3 1.2 Reclassifications to earnings — 5.4 (1.8) 3.6 Balance at June 30, 2020 $ (69.2) $ (161.6) $ (0.3) $ (231.1) (1) OCI is defined as other comprehensive income (loss).
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: Three Months Ended Nine Months Ended Affected Line Item in the Details of AOCI Components 2021 2020 2021 2020 Gain / (Loss) on cash flow hedges Foreign exchange contracts $ (0.5) $ 1.0 $ (3.7) $ 2.6 Other income, net (0.5) 1.0 (3.7) 2.6 (0.1) 0.3 (1.1) 0.8 Income tax provision (0.4) 0.7 (2.6) 1.8 Amortization of defined benefit pension and postretirement items Actuarial losses $ (2.4) $ (2.2) $ (7.0) $ (6.8) (1) Settlements — (0.3) — (0.7) (1) (2.4) (2.5) (7.0) (7.5) (0.7) (0.7) (2.0) (2.1) Income tax provision (1.7) (1.8) (5.0) (5.4) Total reclassifications for the period $ (2.1) $ (1.1) $ (7.6) $ (3.6) (1) These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	9 Months Ended
	Jun. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) June 30, September 30, Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ 2.2 $ (3.0) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ 0.7 $ (0.6) (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ (0.2) $ (1.6) $ 1.5 $ 0.4 Gain (loss) reclassified from AOCI into income (1) (2) (0.5) 1.0 (3.7) 2.6 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ (1.2) $ 0.3 $ 0.7 $ (0.2) (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk.
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: At June 30, 2021 At September 30, 2020 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 3.6 $ (0.9) $ — $ (3.7) Gross amounts offset in the balance sheet (0.1) 0.3 — 0.1 Net amounts of assets (liabilities) presented in the balance sheet $ 3.5 $ (0.6) $ — $ (3.6) (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: June 30, September 30, Liabilities at estimated fair value: Deferred compensation $ (28.4) $ (33.9) Derivatives - foreign currency contracts 2.9 (3.6) Net liabilities at estimated fair value $ (25.5) $ (37.5)

Segment Data (Tables)

Segment Data (Tables)	9 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net Sales Wet Shave $ 304.9 $ 278.0 $ 876.7 $ 835.5 Sun and Skin Care 195.2 136.9 457.7 369.5 Feminine Care 73.6 69.0 209.7 229.1 All Other — — — 26.8 Total net sales $ 573.7 $ 483.9 $ 1,544.1 $ 1,460.9 Segment Profit Wet Shave $ 43.1 $ 44.6 $ 141.6 $ 142.0 Sun and Skin Care 45.0 23.5 86.4 67.9 Feminine Care 13.7 12.0 28.1 43.4 All Other — — — 3.1 Total segment profit 101.8 80.1 256.1 256.4 General corporate and other expenses (15.7) (17.7) (41.2) (41.9) Restructuring and related costs (1) (8.2) (10.4) (18.1) (30.8) Cost of early retirement of long-term debt — (26.2) (26.1) (26.2) Acquisition and integration costs (2) (1.3) (0.3) (4.6) (32.0) Gain on sale of Infant and Pet Care business — — — 4.1 COVID-19 expense (3) — (3.9) — (3.9) Feminine and Infant Care evaluation costs (4) — — — (0.3) Amortization of intangibles (5.5) (4.2) (16.6) (12.7) Interest and other expense, net (17.2) (12.1) (50.9) (49.6) Total earnings before income taxes $ 53.9 $ 5.3 $ 98.6 $ 63.1 (1) Includes pre-tax SG&A of $2.8 and $6.2 for the three and nine months ended June 30, 2021, respectively, and $2.3 and $10.0 for the three and nine months ended June 30, 2020, respectively, associated with certain information technology enablement expenses and incentive and retention compensation expenses for Project Fuel. Additionally, pre-tax Cost of products sold of $0.2 and $0.3 for the three and nine months ended June 30, 2021, respectively, and $0.1 and $0.2 for the three and nine months ended June 30, 2020, respectively, related to inventory write-offs associated with Project Fuel is included. (2) Includes pre-tax SG&A of $1.3 and $3.3 for the three and nine months ended June 30, 2021, respectively, and $0.3 and $32.0 for the three and nine months ended June 30, 2020, respectively, related to acquisition and integration costs. Additionally, Cost of products sold of $1.3 related to the valuation of acquired inventory for the nine months ended June 30, 2021 is included. (3) Includes pre-tax Cost of products sold of $3.9 for the three and nine months ended June 30, 2020 which included incremental costs as a result of the COVID-19 pandemic incurred by the Company related to higher benefit and emergency payments, supplies and freight. (4) Includes pre-tax SG&A of $0.3 for the nine months ended June 30, 2020.
Schedule of Sales by Geographic Area	The following table presents the Company’s net sales by geographic area: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net Sales to Customers United States $ 336.4 $ 277.4 $ 889.0 $ 830.8 International 237.3 206.5 655.1 630.1 Total net sales $ 573.7 $ 483.9 $ 1,544.1 $ 1,460.9
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Razors and blades $ 271.9 $ 244.9 $ 780.6 $ 735.3 Tampons, pads, and liners 73.6 69.0 209.7 229.1 Sun care products 143.9 94.0 275.7 246.3 Grooming products 32.4 15.6 108.6 55.3 Wipes and other skin care 18.9 27.3 73.4 67.9 Shaving gels and creams 33.0 33.1 96.1 100.2 Infant care and other — — — 26.8 Total net sales $ 573.7 $ 483.9 $ 1,544.1 $ 1,460.9

Background and Basis of Prese_2

Background and Basis of Presentation (Details)	Jun. 30, 2021country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which Edgewell operates	20
Number of countries with retail operations	50

Business Combinations and Div_2

Business Combinations and Divestitures (Details) - USD ($) $ in Millions		Sep. 02, 2020	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 17, 2020	Sep. 30, 2020	Dec. 17, 2019
Business Acquisition [Line Items]
Goodwill acquired			$ 1,166.9		$ 1,166.9			$ 1,159.7
Acquisition and integration costs	[1]		1.3	$ 0.3	4.6	$ 32
Divestiture
Gain on sale of Infant and Pet Care business			0	$ 0	0	(4.1)
Infant and Pet Care | Disposal group, not discontinued operations
Divestiture
Divestiture, sale price									$ 122.5
Proceeds from sale of Infant and Pet Care business							$ 115
Proceeds from sale receivable, current									5
Disposal, inventory									18.8
Disposal, fixed assets									3.6
Disposal, goodwill and intangible assets									$ 77.8
Gain on sale of Infant and Pet Care business						$ 4.1
Cremo [Member]
Business Acquisition [Line Items]
Acquisition close date		Sep. 2, 2020
Business combinations, net assets acquired		$ 234.6
Business Combinations, working capital and other net assets		11.5
Business combinations, cash acquired		0.7
Business combinations, intangible assets acquired		95.1
Goodwill acquired		$ 128
Weighted average useful life of acquired intangible assets		17 years
Cremo [Member] | Selling, general and administrative expenses
Business Acquisition [Line Items]
Acquisition and integration costs			$ 1.3		3.3
Cremo [Member] | Cost of products sold
Business Acquisition [Line Items]
Acquisition and integration costs					$ 1.3
[1]	Includes pre-tax SG&A of $1.3 and $3.3 for the three and nine months ended June 30, 2021, respectively, and $0.3 and $32.0 for the three and nine months ended June 30, 2020, respectively, related to acquisition and integration costs. Additionally, Cost of products sold of $1.3 related to the valuation of acquired inventory for the nine months ended June 30, 2021 is included. (3) Includes pre-tax Cost of products sold of $3.9 for the three and nine months ended June 30, 2020 which included incremental costs as a result of the COVID-19 pandemic incurred by the Company related to higher benefit and emergency payments, supplies and freight.

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Restructuring Cost and Reserve [Line Items]
Total restructuring	[1]	$ 8.2	$ 10.4	$ 18.1	$ 30.8
Project Fuel
Restructuring Cost and Reserve [Line Items]
Severance Costs		1.3	5.2	5.6	7.2
Asset Impairment and Accelerated Depreciation		0.2	0.6	0.4	1.6
Other Restructuring Costs		6.7	4.6	12.1	22
Total restructuring		8.2	10.4	18.1	30.8
Project Fuel | Wet Shave
Restructuring Cost and Reserve [Line Items]
Severance Costs		0.7	0	1.6	0.2
Asset Impairment and Accelerated Depreciation		0.2	0.6	0.4	1.6
Other Restructuring Costs		0.3	1.9	1.1	7.7
Total restructuring		1.2	2.5	3.1	9.5
Project Fuel | Sun and Skin Care
Restructuring Cost and Reserve [Line Items]
Severance Costs		0	0.2	0.1	0.2
Asset Impairment and Accelerated Depreciation		0	0	0	0
Other Restructuring Costs		0	0.2	0.1	0.4
Total restructuring		0	0.4	0.2	0.6
Project Fuel | Feminine Care
Restructuring Cost and Reserve [Line Items]
Severance Costs		0	0	0	0
Asset Impairment and Accelerated Depreciation		0	0	0	0
Other Restructuring Costs		0.3	0.1	0.3	0.3
Total restructuring		0.3	0.1	0.3	0.3
Project Fuel | Corporate
Restructuring Cost and Reserve [Line Items]
Severance Costs		0.6	5	3.9	6.8
Asset Impairment and Accelerated Depreciation		0	0	0	0
Other Restructuring Costs		6.1	2.4	10.6	13.6
Total restructuring		$ 6.7	$ 7.4	$ 14.5	$ 20.4
[1]	Includes pre-tax SG&A of $2.8 and $6.2 for the three and nine months ended June 30, 2021, respectively, and $2.3 and $10.0 for the three and nine months ended June 30, 2020, respectively, associated with certain information technology enablement expenses and incentive and retention compensation expenses for Project Fuel. Additionally, pre-tax Cost of products sold of $0.2 and $0.3 for the three and nine months ended June 30, 2021, respectively, and $0.1 and $0.2 for the three and nine months ended June 30, 2020, respectively, related to inventory write-offs associated with Project Fuel is included.

Restructuring Charges (Schedu_2

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Restructuring Reserve [Roll Forward]
Restructuring and related costs	[1]	$ 8.2	$ 10.4	$ 18.1	$ 30.8
Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance				5.4
Restructuring and related costs		8.2	$ 10.4	18.1	$ 30.8
Other	[2]			0.1
Utilized - Cash Payments				(19)
Utilized - Non-Cash				(0.4)
Ending Balance		4.2		4.2
Employee Severance [Member] | Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance				4.3
Restructuring and related costs				5.6
Other	[2]			0.1
Utilized - Cash Payments				(9.6)
Utilized - Non-Cash				0
Ending Balance		0.4		0.4
Asset Impairment and Accelerated Depreciation [Member] | Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance				0
Restructuring and related costs				0.4
Other	[2]			0
Utilized - Cash Payments				0
Utilized - Non-Cash				(0.4)
Ending Balance		0		0
Other Restructuring [Member] | Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance				1.1
Restructuring and related costs				12.1
Other	[2]			0
Utilized - Cash Payments				(9.4)
Utilized - Non-Cash				0
Ending Balance		$ 3.8		$ 3.8
[1]	Includes pre-tax SG&A of $2.8 and $6.2 for the three and nine months ended June 30, 2021, respectively, and $2.3 and $10.0 for the three and nine months ended June 30, 2020, respectively, associated with certain information technology enablement expenses and incentive and retention compensation expenses for Project Fuel. Additionally, pre-tax Cost of products sold of $0.2 and $0.3 for the three and nine months ended June 30, 2021, respectively, and $0.1 and $0.2 for the three and nine months ended June 30, 2020, respectively, related to inventory write-offs associated with Project Fuel is included.
[2]	Includes the impact of currency translation.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income tax provision	$ 13.1	$ 0.6	$ 25.7	$ 16.5
Earnings before income taxes	$ 53.9	$ 5.3	$ 98.6	$ 63.1
Effective tax rate	24.20%	11.90%	26.10%	26.10%

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	54.4	54.3	54.4	54.3
Effect of dilutive securities (in shares)	1	0.3	0.7	0.2
Diluted weighted-average shares outstanding (in shares)	55.4	54.6	55.1	54.5
RSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	1	0.3	0.7	0.2
RSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)		0.1		0.1
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.9	0.7	0.9	0.7

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2021	Sep. 30, 2020
Goodwill [Line Items]
Goodwill, Gross	$ 1,537.9	$ 1,530.7
Accumulated goodwill impairment loss	371	371
Goodwill [Roll Forward]
Beginning balance	1,159.7
Goodwill, Acquired During Period	0.3
Cumulative translation adjustment	(6.9)
Ending balance	1,166.9
Wet Shave
Goodwill [Line Items]
Goodwill, Gross	970.1	967.2
Accumulated goodwill impairment loss	369	369
Goodwill [Roll Forward]
Beginning balance	598.2
Goodwill, Acquired During Period	0
Cumulative translation adjustment	(2.9)
Ending balance	601.1
Sun and Skin Care
Goodwill [Line Items]
Goodwill, Gross	358.1	356.8
Accumulated goodwill impairment loss	2	2
Goodwill [Roll Forward]
Beginning balance	354.8
Goodwill, Acquired During Period	0.3
Cumulative translation adjustment	(1)
Ending balance	356.1
Feminine Care
Goodwill [Line Items]
Goodwill, Gross	209.7	206.7
Accumulated goodwill impairment loss	0	$ 0
Goodwill [Roll Forward]
Beginning balance	206.7
Goodwill, Acquired During Period	0
Cumulative translation adjustment	(3)
Ending balance	$ 209.7

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 557.9		$ 557.9		$ 555.2
Amortizable intangible assets, accumulated amortization	246.4		246.4		228.5
Amortizable intangible assets, net	311.5		311.5		326.7
Amortization of intangibles	5.5	$ 4.2	16.6	$ 12.7
Amortizable intangible assets, amortization expense, remainder of 2021	5.5		5.5
Amortizable intangible assets, amortization expense, fiscal 2022	22.1		22.1
Amortizable intangible assets, amortization expense, fiscal 2023	22		22
Amortizable intangible assets, amortization expense, fiscal 2024	21.9		21.9
Amortizable intangible assets, amortization expense, fiscal 2025	21.9		21.9
Amortizable intangible assets, amortization expense, fiscal 2026	21.7		21.7
Amortizable intangible assets, amortization expense, after fiscal 2026	196.4		196.4
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	256.3		256.3		256.2
Amortizable intangible assets, accumulated amortization	54.7		54.7		45.4
Amortizable intangible assets, net	201.6		201.6		210.8
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	79.3		79.3		79.1
Amortizable intangible assets, accumulated amortization	75.9		75.9		75.3
Amortizable intangible assets, net	3.4		3.4		3.8
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	222.3		222.3		219.9
Amortizable intangible assets, accumulated amortization	115.8		115.8		107.8
Amortizable intangible assets, net	$ 106.5		$ 106.5		$ 112.1

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2021	Sep. 30, 2020
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 602.9	$ 601.4
Indefinite-lived intangible assets, increase	1.5
Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	183.9	183.1
Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	389.1	388.4
Feminine Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 29.9	$ 29.9

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Inventories
Raw materials and supplies	$ 56.6	$ 58.5
Work in process	79.5	71.5
Finished products	223.1	184.1
Total inventories	359.2	314.1
Other Current Assets
Miscellaneous receivables	28.9	23.3
Inventory returns receivable	1	1
Prepaid expenses	72.3	64.8
Value added tax collectible from customers	20.1	20.4
Income taxes receivable	22	26.3
Other	11.4	10.2
Total other current assets	155.7	146
Property, Plant and Equipment
Land	19.3	19.3
Buildings	144	142.2
Machinery and equipment	1,042.4	1,014.2
Capitalized software costs	55.4	53.6
Construction in progress	38.4	32.7
Total gross property, plant and equipment	1,299.5	1,262
Accumulated depreciation and amortization	(941.4)	(891.1)
Total property, plant and equipment, net	358.1	370.9
Other Current Liabilities
Accrued advertising, sales promotion and allowances	63	49.4
Accrued trade allowances	29.5	30.8
Accrued salaries, vacations and incentive compensation	50.7	62.6
Income taxes payable	12.5	13.4
Returns reserve	45.9	44.8
Restructuring reserve	4.2	5.4
Value added tax payable	9.3	6.8
Deferred compensation	5.9	5.9
Short term lease obligation	10.7	9.1
Customer advance payments	3.4	1.4
Dividends payable	8.2	0
Other	63.1	77.9
Total other current liabilities	306.4	307.5
Other Liabilities
Pensions and other retirement benefits	119	121
Deferred compensation	22.6	28.2
Noncurrent lease obligation	42.4	34.6
Other non-current liabilities	67.5	73.3
Total other liabilities	$ 251.5	$ 257.1

Leases (Summary of Lease Inform

Leases (Summary of Lease Information) (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
	Jun. 30, 2021		Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020
Leases [Abstract]
Operating lease, right-of-use asset	$ 52.9			$ 52.9		$ 43.5
Short term lease obligation	10.7			10.7		9.1
Noncurrent lease obligation	42.4			42.4		34.6
Total lease obligation	$ 53.1			$ 53.1		$ 43.7
Operating lease, weighted average remaining lease term	10 years			10 years		12 years
Operating lease, weighted average discount rate, percent	6.60%			6.60%		7.20%
Operating lease, expense	$ 3.6	[1]	$ 3.3	$ 11	$ 10.4
Right-of-use asset obtained in exchange for operating lease liability	1.1		0.5	18.8	1.1
Operating lease, payments	$ 3.6		$ 3.4	$ 11	$ 10.4
[1]	Lease expense is included in Cost of products sold or SG&A expense based on the nature of the lease. Short-term lease expense is excluded from this amount and is not material.

Leases (Operating Lease Payment

Leases (Operating Lease Payment Schedule) (Details) - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Leases [Abstract]
Lessee, operating lease, payment due current year	$ 3.3
Lessee, operating lease, payment due year two	12
Lessee, operating lease, payment due year three	10.1
Lessee, operating lease, payment due year four	8
Lessee, operating lease, payment due year five	7.1
Lessee, operating lease, payment due after year five	39.2
Lessee, operating lease, payments due	79.7
Lessee, operating lease, undiscounted excess amount	26.6
Total lease obligation	$ 53.1	$ 43.7
Operating lease, weighted average remaining lease term	10 years	12 years

Accounts Receivable Facility (N

Accounts Receivable Facility (Narrative) (Details) - Accounts receivable sales agreement - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020
Transfer of Financial Assets Accounted for as Sales [Line Items]
Accounts receivable sold through AR Facility	$ 293.9	$ 245.3	$ 634.2	$ 646.5
Transfer of accounts receivable, sales amount derecognized	136.1		136.1		$ 77
Loss on sale of accounts receivable	$ 0.2	$ 0.2	$ 0.6	$ 1.1

Debt (Details)

Debt (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Sep. 30, 2020
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 1,250		$ 1,250		$ 1,250
Unamortized discount and debit issuance costs	[1],[2]	16.4		16.4		12.1
Long-term debt		1,233.6		1,233.6		1,237.9
Notes payable		24.8		24.8		21.1
Cost of early retirement of long-term debt		0	$ 26.2	26.1	$ 26.2
Premium for extinguishment on debt				25.5
Senior notes | Senior Notes, Due 2022
Debt Instrument [Line Items]
Total long-term debt, including current maturities		0		0		500
Unamortized discount						$ 0.2
Long term debt, stated interest rate						4.70%
Unamortized debt issuance costs						$ 0.6
Write off of Deferred Debt Issuance Cost				0.6
Senior notes | Senior Notes, Due 2028
Debt Instrument [Line Items]
Total long-term debt, including current maturities		750		750		750
Unamortized debt issuance costs		10.2		10.2		11.3
Senior notes | Senior Notes, Due 2029
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 500		$ 500		$ 0
Long term debt, stated interest rate		4.125%		4.125%
Unamortized debt issuance costs		$ 6.2		$ 6.2
[1]	At June 30, 2021, the balance for the Senior Notes due 2028 and the Senior Notes due 2029 are reflected net of debt issuance costs of $10.2 and $6.2, respectively. At September 30, 2020, the balance for the Senior Notes due 2022 and the Senior Notes due 2028 are reflected net of debt issuance costs of $0.6 and $11.3, respectively.
[2]	At September 30, 2020, the balance for the Senior Notes due 2022 was reflected net of discount of $0.2.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Retirement Benefits [Abstract]
Service cost	$ 1.1	$ 1.1	$ 3.3	$ 3.2
Interest cost	2.5	3.4	7.4	10.3
Expected return on plan assets	(5.6)	(5.8)	(16.8)	(17.3)
Recognized net actuarial loss	2.3	2.2	6.9	6.8
Settlement loss recognized	0	0.3	0	0.7
Net periodic cost	$ 0.3	$ 1.2	$ 0.8	$ 3.7

Equity (Details)

Equity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2021	Jun. 30, 2021	Jan. 26, 2018
Equity [Abstract]
Share repurchase authorization			10
Treasury shares repurchased (in shares)		0.3
Treasury shares repurchased (in usd)		$ 9.2
Share repurchase authorization, remaining	9.7	9.7
Dividends declared (per share)	$ 0.15
Dividends declared		$ 25.4

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		9 Months Ended
		Jun. 30, 2021	Jun. 30, 2020
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (191.6)	$ (235.9)
OCI before reclassifications	[1]	17.6	1.2
Reclassifications to earnings		7.6	3.6
Ending balance		(166.4)	(231.1)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(47.4)	(77.3)
OCI before reclassifications	[1]	23	8.1
Reclassifications to earnings		0	0
Ending balance		(24.4)	(69.2)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(142.1)	(159.8)
OCI before reclassifications	[1]	(6.3)	(7.2)
Reclassifications to earnings		5	5.4
Ending balance		(143.4)	(161.6)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(2.1)	1.2
OCI before reclassifications	[1]	0.9	0.3
Reclassifications to earnings		2.6	(1.8)
Ending balance		$ 1.4	$ (0.3)
[1]	OCI is defined as other comprehensive income (loss).

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions	3 Months Ended				9 Months Ended
	Jun. 30, 2021		Jun. 30, 2020		Jun. 30, 2021	Jun. 30, 2020
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings					$ (7.6)	$ (3.6)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax	$ (0.5)		$ 1		(3.7)	2.6
Gains and losses on cash flow hedges, foreign exchange contracts, tax	(0.1)		0.3		(1.1)	0.8
Gains and losses on cash flow hedges, foreign exchange contracts, after tax	(0.4)		0.7		(2.6)	1.8
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	(2.4)	[1]	(2.2)	[1]	(7)	(6.8)
Amortization of defined benefit pension and postretirement items, settlement loss, before tax	0		0.3		0	0.7
Amortization of defined benefit pension and postretirement items, before tax	(2.4)		(2.5)		(7)	(7.5)
Amortization of defined benefit pension and postretirement items, tax	(0.7)		(0.7)		(2)	(2.1)
Amortization of defined benefit pension and postretirement items, after tax	(1.7)		(1.8)		(5)	(5.4)
Reclassifications to earnings	(2.1)		(1.1)		(7.6)	(3.6)
Other expense (income), net | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax	$ (0.5)		$ 1		$ (3.7)	$ 2.6
[1]	These AOCI components are included in the computation of net periodic cost. See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2021USD ($)contracts	Jun. 30, 2020USD ($)	Jun. 30, 2021USD ($)contracts	Jun. 30, 2020USD ($)	Sep. 30, 2020USD ($)
Derivative [Line Items]
Long-term debt		$ 1,250		$ 1,250		$ 1,250
Fixed rate
Derivative [Line Items]
Long-term debt		1,250		1,250		1,250
Fair value of long-term debt		$ 1,314.6		$ 1,314.6		1,323.1
Not designated as hedge | FX contract
Derivative [Line Items]
Open foreign currency contracts | contracts		5		5
Derivative, notional amount		$ 42		$ 42
Cash flow hedge | Designated as hedge | FX contract
Derivative [Line Items]
Estimated fair value of derivative		$ (2.2)		$ (2.2)		$ (3)
Open foreign currency contracts | contracts		64		64
Derivative, notional amount		$ 133.1		$ 133.1
Other expense (income), net | Not designated as hedge | FX contract
Derivative [Line Items]
Gain (loss) recognized in income	[1]	$ (1.2)	$ 0.3	$ 0.7	$ (0.2)
[1]	Gain (loss) was recorded in Other income, net.

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		Jun. 30, 2021	Sep. 30, 2020
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 0.7	$ (0.6)
Cash flow hedge | Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ 2.2	$ (3)
[1]	All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_5

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	[1]	$ (0.2)	$ (1.6)	$ 1.5	$ 0.4
Other expense (income), net | Designated as hedge | Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from AOCI into income (effective portion)	[1],[2]	(0.5)	1	(3.7)	2.6
Other expense (income), net | Not designated as hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	[2]	$ 1.2	$ (0.3)	$ (0.7)	$ 0.2
[1]	Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and have been deemed highly effective by the Company in offsetting associated risk.
[2]	Gain (loss) was recorded in Other income, net.

Financial Instruments and Ris_6

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions		Jun. 30, 2021	Sep. 30, 2020
Derivative [Line Items]
Gross amounts of recognized assets	[1]	$ 3.6	$ 0
Gross amounts of recognized liabilities	[2]	(0.9)	(3.7)
Gross amounts offset in the balance sheet	[1]	(0.1)	0
Gross amounts offset in the balance sheet	[2]	0.3	0.1
Net amounts of assets presented in the balance sheet	[1]	3.5	0
Net amounts of liabilities presented in the balance sheet	[2]	$ (0.6)	$ (3.6)
[1]	All derivative assets are presented in Other current assets or Other assets.
[2]	All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_7

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Jun. 30, 2021	Sep. 30, 2020
Derivative [Line Items]
Deferred compensation	$ (28.4)	$ (33.9)
Derivatives - foreign currency contracts	2.9	(3.6)
Net liabilities at estimated fair value	$ (25.5)	$ (37.5)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Segment Reporting Information [Line Items]
Net sales		$ 573.7	$ 483.9	$ 1,544.1	$ 1,460.9
Segment profit		71.1	43.5	175.6	134.7
Restructuring and related costs	[1]	8.2	10.4	18.1	30.8
Acquisition and integration costs	[2]	1.3	0.3	4.6	32
Gain on sale of Infant and Pet Care business		0	0	0	(4.1)
Covid-19 pandemic expenses	[3]	0	3.9	0	3.9
Feminine and Infant Care evaluation costs	[4]	0	0	0	0.3
Amortization of intangibles		5.5	4.2	16.6	12.7
Interest and other expense, net		17.2	12.1	50.9	49.6
Earnings before income taxes		53.9	5.3	98.6	63.1
Cost of early retirement of long-term debt		0	(26.2)	(26.1)	(26.2)
Wet Shave
Segment Reporting Information [Line Items]
Net sales		304.9	278	876.7	835.5
Segment profit		43.1	44.6	141.6	142
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales		195.2	136.9	457.7	369.5
Segment profit		45	23.5	86.4	67.9
Feminine Care
Segment Reporting Information [Line Items]
Net sales		73.6	69	209.7	229.1
Segment profit		13.7	12	28.1	43.4
All Other
Segment Reporting Information [Line Items]
Net sales		0	0	0	26.8
Segment profit		0	0	0	3.1
Total Segments
Segment Reporting Information [Line Items]
Segment profit		101.8	80.1	256.1	256.4
Corporate
Segment Reporting Information [Line Items]
General corporate and other expenses		15.7	17.7	41.2	41.9
Project Fuel
Segment Reporting Information [Line Items]
Restructuring and related costs		8.2	10.4	18.1	30.8
Project Fuel | Wet Shave
Segment Reporting Information [Line Items]
Restructuring and related costs		1.2	2.5	3.1	9.5
Project Fuel | Sun and Skin Care
Segment Reporting Information [Line Items]
Restructuring and related costs		0	0.4	0.2	0.6
Project Fuel | Feminine Care
Segment Reporting Information [Line Items]
Restructuring and related costs		0.3	0.1	0.3	0.3
Project Fuel | Corporate
Segment Reporting Information [Line Items]
Restructuring and related costs		6.7	7.4	14.5	20.4
IT enablement | Project Fuel | Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Restructuring and related costs		2.8	2.3	6.2	10
Inventory obsolescence | Project Fuel | Cost of products sold
Segment Reporting Information [Line Items]
Restructuring and related costs		$ 0.2	$ 0.1	$ 0.3	$ 0.2
[1]	Includes pre-tax SG&A of $2.8 and $6.2 for the three and nine months ended June 30, 2021, respectively, and $2.3 and $10.0 for the three and nine months ended June 30, 2020, respectively, associated with certain information technology enablement expenses and incentive and retention compensation expenses for Project Fuel. Additionally, pre-tax Cost of products sold of $0.2 and $0.3 for the three and nine months ended June 30, 2021, respectively, and $0.1 and $0.2 for the three and nine months ended June 30, 2020, respectively, related to inventory write-offs associated with Project Fuel is included.
[2]	Includes pre-tax SG&A of $1.3 and $3.3 for the three and nine months ended June 30, 2021, respectively, and $0.3 and $32.0 for the three and nine months ended June 30, 2020, respectively, related to acquisition and integration costs. Additionally, Cost of products sold of $1.3 related to the valuation of acquired inventory for the nine months ended June 30, 2021 is included. (3) Includes pre-tax Cost of products sold of $3.9 for the three and nine months ended June 30, 2020 which included incremental costs as a result of the COVID-19 pandemic incurred by the Company related to higher benefit and emergency payments, supplies and freight.
[3]	Segment net sales and profitability are presented below: Three Months Ended Nine Months Ended 2021 2020 2021 2020 Net Sales Wet Shave $ 304.9 $ 278.0 $ 876.7 $ 835.5 Sun and Skin Care 195.2 136.9 457.7 369.5 Feminine Care 73.6 69.0 209.7 229.1 All Other — — — 26.8 Total net sales $ 573.7 $ 483.9 $ 1,544.1 $ 1,460.9 Segment Profit Wet Shave $ 43.1 $ 44.6 $ 141.6 $ 142.0 Sun and Skin Care 45.0 23.5 86.4 67.9 Feminine Care 13.7 12.0 28.1 43.4 All Other — — — 3.1 Total segment profit 101.8 80.1 256.1 256.4 General corporate and other expenses (15.7) (17.7) (41.2) (41.9) Restructuring and related costs (1) (8.2) (10.4) (18.1) (30.8) Cost of early retirement of long-term debt — (26.2) (26.1) (26.2) Acquisition and integration costs (2) (1.3) (0.3) (4.6) (32.0) Gain on sale of Infant and Pet Care business — — — 4.1 COVID-19 expense (3) — (3.9) — (3.9) Feminine and Infant Care evaluation costs (4) — — — (0.3) Amortization of intangibles (5.5) (4.2) (16.6) (12.7) Interest and other expense, net (17.2) (12.1) (50.9) (49.6) Total earnings before income taxes $ 53.9 $ 5.3 $ 98.6 $ 63.1 (1) Includes pre-tax SG&A of $2.8 and $6.2 for the three and nine months ended June 30, 2021, respectively, and $2.3 and $10.0 for the three and nine months ended June 30, 2020, respectively, associated with certain information technology enablement expenses and incentive and retention compensation expenses for Project Fuel. Additionally, pre-tax Cost of products sold of $0.2 and $0.3 for the three and nine months ended June 30, 2021, respectively, and $0.1 and $0.2 for the three and nine months ended June 30, 2020, respectively, related to inventory write-offs associated with Project Fuel is included. (2) Includes pre-tax SG&A of $1.3 and $3.3 for the three and nine months ended June 30, 2021, respectively, and $0.3 and $32.0 for the three and nine months ended June 30, 2020, respectively, related to acquisition and integration costs. Additionally, Cost of products sold of $1.3 related to the valuation of acquired inventory for the nine months ended June 30, 2021 is included. (3) Includes pre-tax Cost of products sold of $3.9 for the three and nine months ended June 30, 2020 which included incremental costs as a result of the COVID-19 pandemic incurred by the Company related to higher benefit and emergency payments, supplies and freight. (4) Includes pre-tax SG&A of $0.3 for the nine months ended June 30, 2020.
[4]	Includes pre-tax SG&A of $0.3 for the nine months ended June 30, 2020.

Segment Data Segment Data (Sche

Segment Data Segment Data (Schedule of Sales by Geographical Area) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue from External Customer [Line Items]
Net sales	$ 573.7	$ 483.9	$ 1,544.1	$ 1,460.9
United States
Revenue from External Customer [Line Items]
Net sales	336.4	277.4	889	830.8
International
Revenue from External Customer [Line Items]
Net sales	$ 237.3	$ 206.5	$ 655.1	$ 630.1

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue from External Customer [Line Items]
Net sales	$ 573.7	$ 483.9	$ 1,544.1	$ 1,460.9
Razors and blades
Revenue from External Customer [Line Items]
Net sales	271.9	244.9	780.6	735.3
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	73.6	69	209.7	229.1
Sun care products
Revenue from External Customer [Line Items]
Net sales	143.9	94	275.7	246.3
Grooming products
Revenue from External Customer [Line Items]
Net sales	32.4	15.6	108.6	55.3
Wipes and other skin care products
Revenue from External Customer [Line Items]
Net sales	18.9	27.3	73.4	67.9
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	33	33.1	96.1	100.2
Infant care and other
Revenue from External Customer [Line Items]
Net sales	$ 0	$ 0	$ 0	$ 26.8

Uncategorized Items - epc-20210

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	$ 72,800,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	$ 170,300,000